HERON THERAPEUTICS, INC. /DE/ Shareholders' Equity
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Shareholders' Equity of $6.91 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $6.91M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $9.14M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $14.33M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $14.88M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $6.91M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $9.14M 10-Q · filed 2026-08-10 |
| 2025-12-31 | $14.33M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $14.88M 10-Q · filed 2025-11-04 |
| 2025-06-30 | -$27.26M 10-Q · filed 2026-08-10 |
| 2025-03-31 | -$28.45M 10-Q · filed 2026-08-10 |
| 2024-12-31 | -$33.65M 10-Q · filed 2026-08-10 |
| 2024-09-30 | -$40.01M 10-Q · filed 2025-11-04 |
| 2024-06-30 | -$37.94M 10-Q · filed 2025-11-04 |
| 2024-03-31 | -$33.77M 10-Q · filed 2025-11-04 |
| 2023-12-31 | -$33.97M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$27.79M 10-Q · filed 2024-11-12 |
| 2023-06-30 | -$39.28M 10-Q · filed 2024-11-12 |
| 2023-03-31 | -$11.43M 10-Q · filed 2024-11-12 |
| 2022-12-31 | $13.57M 10-K · filed 2026-02-26 |
| 2022-09-30 | $22.45M 10-Q · filed 2023-11-14 |
| 2022-06-30 | -$21.74M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $23.96M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $77.57M 10-K · filed 2025-02-27 |
| 2021-09-30 | $118.84M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $160.11M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $196.22M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $236.49M 10-K · filed 2023-03-29 |
| 2020-09-30 | $277.15M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $324.06M 10-Q · filed 2021-11-03 |
| 2020-03-31 | $365.47M 10-Q · filed 2021-11-03 |
| 2019-12-31 | $403.83M 10-K · filed 2022-02-28 |
| 2019-09-30 | $285.44M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $305.36M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $331.81M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $370.16M 10-K · filed 2022-02-28 |
| 2018-09-30 | $406.81M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $431.89M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $92.21M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $131.14M 10-K · filed 2021-02-24 |
| 2017-09-30 | $40.05M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $69.08M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $102.16M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$21.25M 10-K · filed 2020-03-02 |
| 2016-09-30 | $17.88M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $57.84M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $92.68M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $118.11M 10-K · filed 2019-02-22 |
| 2015-09-30 | $141.70M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $159.87M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $48.00M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $63.06M 10-K · filed 2018-02-27 |
| 2014-09-30 | $81.01M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $97.85M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $55.41M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $68.94M 10-K · filed 2017-02-23 |
| 2013-09-30 | $20.87M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $28.50M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $41.38M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $51.82M 10-K · filed 2016-02-19 |
| 2012-09-30 | $57.52M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $11.12M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $11.63M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $15.75M 10-K · filed 2015-03-13 |
| 2011-09-30 | $19.19M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $18.89M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $1.32M 10-K · filed 2014-03-07 |
| 2009-12-31 | $6.80M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |